National Security Commission on Emerging Biotechnology (NSCEB)

Our first report is now live on our website! After a year of work, the Commission discusses our work at the intersection of #nationalsecurity and emerging #biotechnology as well as the research plan that will inform our comprehensive policy recommendations to be issued in 2024. It also highlights the concrete actions we have already taken to advance emerging biotechnology in the United States.  After exploring our report, we'd love to hear your insights. Please share your thoughts in the comments below or with us at [email protected]. Follow the link below to review our work: www.biotech.senate.gov

To the NSCEB’s summer interns, thank you for your contributions to the Commission’s work. We can’t wait to see where you go next!

The National Security Commission on Emerging Biotechnology is pleased that Commissioner Alexander Titus will be a Keynote Speaker at the 2024 Annual Nucleate Alumni Summit. Nucleate is a global platform for networking and knowledge sharing among the next wave of enthusiastic biotech innovators. Commissioner Titus joins an impressive lineup of speakers and experts working with Nucleate to support a vibrant future for biotech. 

What is gene synthesis?    Gene synthesis is the process of creating physical genes based on digital sequence data. It can drive #biotechnology innovation in healthcare, agriculture, and so much more!  Dive into gene synthesis and biotech innovation ➡️ https://lnkd.in/evfs3-qV 

Like infrastructure for water, energy, and transportation across the country, the United States needs strong biological data #infrastructure to support #biotechnology advancements and maintain global leadership.   Currently, the U.S. lacks a coordinated and well-maintained data infrastructure, making it harder for researchers to store, analyze, reuse, and share their data. NSCEB’s newest white paper explores how the U.S. can better promote biological data as a strategic national asset and ensure U.S. biotechnology leadership by:  📊 Strengthening U.S. biological data infrastructure  🖥️ Developing data standards to support interoperability  🖊️ Ensuring that data use terms are fit-for-purpose Read more at https://lnkd.in/gZnx5MCq As part of the Commission's work to prepare a bio-ready U.S. Government and bio-literate America, you can find white papers on biotechnology-related topics including Biomanufacturing, AIxBio, Bioliteracy for the Age of Biology, and more at https://biotech.senate.gov

Congratulations to the latest awardees for the Distributed Bioindustrial Manufacturing Program. The NSCEB is excited to see awardees in: 📍Ohio 📍Utah 📍California 📍New York 👉 Learn more about biomanufacturing: https://lnkd.in/eYwqrJA4 👉 View the award announcement: https://lnkd.in/eX8ZYteg

Caltech’s Linde Center for Science, Society, and Policy recently published a report on engineered microbes with actionable recommendations to improve regulatory coordination and clarity.    The Commission is grateful to authors John Marken, Mary Maxon, and Richard Murray for highlighting #NSCEB work, including NSCEB’s bills aimed at improving U.S. biotechnology regulation: the Agriculture Biotechnology Coordination Act and Biotechnology Oversight Coordination Act.    View the report “Policy Recommendations for the Regulation of Engineered Microbes for Environmental Release” at: https://lnkd.in/etVdB72r

Calling all emerging #biotech companies! #NSCEB wants to hear about your company’s workforce needs and how the U.S. government may be uniquely positioned to help. Take our online survey here: https://lnkd.in/eY3SnPFE NSCEB is conducting a survey to gather perspectives from the biotech industry on current and future workforce needs, as well as mechanisms for workforce development. The responses to this survey will help NSCEB develop policies that enable a nimble and prepared biotech workforce.

The CHIPS and Science Act of 2022 has revived semiconductor production in the United States. Now it’s time for biotech to reap the benefits of strong public-private partnerships.    Cultivating regional technology hubs has major payouts not only for the economy, but for U.S. national security by strengthening the American biotechnology industry, shoring up critical supply chains, and developing the next generation of innovative biotechnology solutions.